| Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543960 |
NSE Symbol : CONCORDBIO |
P/E(TTM) : 75.12 |
|
ISIN Demat : INE338H01029 |
Div & Yield% : 0.39 |
EPS(TTM) : 30.06 |
|
Book Value(₹) : 145.80 |
Market Cap(₹Cr) : 23,624.43 |
Face Value(₹) : 1.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 10.46 | 10.46 | 9.51 | 9.51 | 9.51 |
| Reserves | 1,514.79 | 1,281.52 | 1,097.65 | 990.16 | 760.57 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 1,525.25 | 1,291.98 | 1,107.16 | 999.67 | 770.08 |
| Secured Loans | 6.23 | 31.24 | 60.59 | 86.35 | 35.53 |
| Unsecured Loans | 3.51 | 0.31 | 1.91 | 2.93 | 16.53 |
| Total Debt | 9.74 | 31.55 | 62.50 | 89.28 | 52.06 |
| Other Liabilities | 1.96 | 2.30 | 1.87 | 2.10 | 1.59 |
| Total Liabilities | 1,536.95 | 1,325.83 | 1,171.53 | 1,091.05 | 823.73 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 825.51 | 791.69 | 719.94 | 644.29 | 310.15 |
| Less: Accumulated Depreciation | 250.20 | 198.71 | 146.97 | 98.08 | 70.55 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 575.31 | 592.98 | 572.97 | 546.21 | 239.60 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 211.48 | 172.70 | 74.16 | 17.95 | 141.40 |
| Investments | 244.37 | 137.72 | 74.39 | 141.65 | 198.77 |
| Current Assets, Loans & Advances | |||||
| Inventories | 207.95 | 212.31 | 195.12 | 153.61 | 111.23 |
| Sundry Debtors | 349.61 | 273.76 | 232.17 | 177.52 | 183.51 |
| Cash and Bank Balance | 47.02 | 43.45 | 88.93 | 60.82 | 2.59 |
| Loans and Advances | 47.94 | 61.25 | 42.97 | 74.22 | 43.37 |
| Total Current Assets | 652.53 | 590.77 | 559.19 | 466.16 | 340.69 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 124.91 | 128.91 | 119.21 | 73.68 | 99.64 |
| Provisions | 9.40 | 36.47 | 1.75 | 0.66 | 2.08 |
| Total CL & Provisions | 134.30 | 165.39 | 120.96 | 74.34 | 101.72 |
| Net Current Assets | 518.23 | 425.39 | 438.23 | 391.82 | 238.98 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 2.45 | 2.18 | 1.95 | 0.60 | 0.59 |
| Deferred Tax Liability | 30.52 | 25.62 | 22.92 | 18.05 | 15.72 |
| Net Deferred Tax | -28.07 | -23.44 | -20.97 | -17.45 | -15.13 |
| Other Assets | 15.62 | 20.48 | 32.74 | 10.87 | 20.11 |
| Total Assets | 1,536.95 | 1,325.83 | 1,171.52 | 1,091.05 | 823.74 |
| Contingent Liabilities | 14.31 | 14.31 | 13.32 | 3.89 | 3.89 |